USANA Health Sciences' GAAP net income for the 3 months of 2022 was $22.469 million, down 26.6% from $30.621 million in the previous year. Revenue decreased 11.4% to $272.867 million from $307.976 million a year earlier.

USANA Health Sciences' GAAP net income for 2021 was $116.505 million, down 6.5% from $124.664 million in the previous year. Revenues increased 4.6% to $1.187 billion from $1.135 billion a year earlier.

USANA Health Sciences' GAAP net income for 9M 2021 was $96.185 million, up 13.1% from $85.035 million in the prior year. Revenue increased 11.5% to $919.165 million from $824.123 million a year earlier.

USANA Health Sciences' GAAP net income for the six months of 2021 was $68.855 million, up 26.3% from $54.529 million in the prior year. Revenue increased 22.7% to $644.813 million from $525.61 million a year earlier.